Find Polmacoxib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 301692-76-2, Cg100649, 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide, Cg-100649, Ij34d6ypao, Cg 100649
Molecular Formula
C18H16FNO4S
Molecular Weight
361.4  g/mol
InChI Key
IJWPAFMIFNSIGD-UHFFFAOYSA-N
FDA UNII
IJ34D6YPAO

Polmacoxib
Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Localized Primary Osteoarthritis of Hip, and Localized Primary Osteoarthritis of Knee.
1 2D Structure

Polmacoxib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide
2.1.2 InChI
InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)
2.1.3 InChI Key
IJWPAFMIFNSIGD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1(C(=O)C(=C(O1)C2=CC=C(C=C2)S(=O)(=O)N)C3=CC(=CC=C3)F)C
2.2 Other Identifiers
2.2.1 UNII
IJ34D6YPAO
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cg100649

2.3.2 Depositor-Supplied Synonyms

1. 301692-76-2

2. Cg100649

3. 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide

4. Cg-100649

5. Ij34d6ypao

6. Cg 100649

7. 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide

8. 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)-benzenesulfonamide

9. 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxidanylidene-furan-2-yl]benzenesulfonamide

10. Benzenesulfonamide, 4-(3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl)-

11. Polmacoxib [usan:inn]

12. Unii-ij34d6ypao

13. Polmacoxib [usan]

14. Acelex (s. Korea)

15. Polmacoxibcg100649

16. Polmacoxib [inn]

17. Polmacoxib (usan/inn)

18. Polmacoxib [who-dd]

19. Chembl166863

20. Gtpl8316

21. Schembl3233093

22. Ex-a601

23. Dtxsid901029389

24. Zinc589683

25. Bcp15550

26. Bdbm50474760

27. Akos025149767

28. Db12399

29. Sb17177

30. Da-42861

31. Hy-16726

32. Cs-0012326

33. Ft-0700281

34. D10656

35. A857030

36. J-690277

37. Q19598695

38. Cg100649; Cg-100649; Cg 100649

39. 2-(4-tert-butylphenyl)-1h-benzimidazole, 2-[4-(1,1-dimethylethyl)phenyl]-1h-benzimidazole

40. 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone

41. 1427301-99-2

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 361.4 g/mol
Molecular Formula C18H16FNO4S
XLogP32.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass361.07840733 g/mol
Monoisotopic Mass361.07840733 g/mol
Topological Polar Surface Area94.8 Ų
Heavy Atom Count25
Formal Charge0
Complexity672
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

M - Musculo-skeletal system

M01 - Antiinflammatory and antirheumatic products

M01A - Antiinflammatory and antirheumatic products, non-steroids

M01AH - Coxibs

M01AH07 - Polmacoxib


API SUPPLIERS

read-more
read-more

01

Honour Lab Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

02

Precise Group

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

Precise Group

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IFSCC
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Kyongbo Pharmaceutical Co., Ltd

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

Kyongbo Pharmaceutical Co., Ltd

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IFSCC
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

04

Ajanta Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

05

Calidrux Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

06

Hwail Pharm Co., Ltd

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

Hwail Pharm Co., Ltd

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IFSCC
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

07

Excenen PharmaTech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

08

Venkatasai Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

09

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IFSCC
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

10

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IFSCC
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IFSCC
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Hwail Pharm Co., Ltd

South Korea
ECRM CMO & Packaging
Not Confirmed
arrow

Hwail Pharm Co., Ltd

South Korea
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

Registrant Name : Hwail Pharmaceutical Co., Ltd.

Registration Date : 2017-04-03

Registration Number : 2014-7-ND

Manufacturer Name : Hwail Pharmaceutical Co., Lt...

Manufacturer Address : 57, Yakjakgongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do

blank

02

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

Registrant Name : CGINVIZ Co., Ltd.

Registration Date : 2015-02-05

Registration Number : 6-1-ND

Manufacturer Name : Kyungbo Pharmaceutical Co., ...

Manufacturer Address : 174 Silok-ro, Asan-si, Chungcheongnam-do

blank

03

ECRM CMO & Packaging
Not Confirmed
arrow

arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

Registrant Name : Engichem Life Sciences Co., Ltd.

Registration Date : 2021-04-16

Registration Number : 238-8-ND

Manufacturer Name : Engichem Life Sciences Co., ...

Manufacturer Address : 59 Biovalley-ro, Jecheon-si, Chungcheongbuk-do

blank

04

ECRM CMO & Packaging
Not Confirmed
arrow

arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

Registrant Name : Agerson Bio Co., Ltd.

Registration Date : 2024-10-07

Registration Number : 6160-6-ND

Manufacturer Name : Agerson Bio Co., Ltd.

Manufacturer Address : 7 Geumwang Techno 5-gil, Geumwang-eup, Eumseong-gun, Chungcheongbuk-do

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Polmacoxib

About the Company : Honour is a leading global CDMO and a trusted manufacturer of specialty chemicals and ingredients. With seven world-class facilities built to meet global safety and quality standar...

Honour is a leading global CDMO and a trusted manufacturer of specialty chemicals and ingredients. With seven world-class facilities built to meet global safety and quality standards, we are committed to delivering excellence with innovative, holistic solutions to clients across the globe by leveraging our expertise in chemistry. Operating through our two core verticals - Honour Synthesis and Honour Specialty, we embrace the science of partnership and possibilities. Our team of over 2,500 professionals collaborates closely with pharmaceutical, biotechnology, and specialty industries worldwide to develop practical, scalable solutions.
Company Banner

02

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

About the Company : Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Established...

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Established in 1973 and headquartered in Mumbai-India, we are committed to 'Serve Health Care Needs Worldwide'. Ajanta has been consistently providing high quality affordable medicines to patients in different parts of the world. We employ over 4,000 people worldwide and our products are sold in over 40 countries. Ajanta operates with 5 state-of-the art manufacturing facilities that produce high quality pharmaceutical products. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, Cardiovascular, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. In India, we have significant presence in the fast growing specialty therapeutic segments of Cardiovascular, dermatology, ophthalmology and musculoskeletal. With primary focus on new product innovation and introduction, we have been consistently identifying unmet medical needs and introducing many first-to-market products to cater to those needs. Our products provide patient compliance and convenience over existing therapeutic options. Gaining first mover advantage, many of our brands hold leadership positions in their respective sub- therapeutic segments. Ajanta has extensive presence in many countries in Asia, Africa and Latin America with customized product portfolio to suit the needs of each country. Having successfully gone through USFDA inspection, we have started commercial operations in the US market in the first quarter of 2013. With a portfolio of 23 ANDAs which have been filed with the US FDA, we look forward to the US market to be our key growth driver in coming years. We have an advanced Research & Development Centre for finished formulations and Active Pharmaceutical Ingredient (API) synthesis of different dosage forms. ‘Advent’, our R&D centre has a team of over 300 scientists working on innovative products for various markets across the globe. We have acquired strong capabilities for developing generic formulations and process chemistry over the years. Committed to patient care since inception, our focus on specialty segments in India and simultaneous opening of new international markets has been accelerating our growth over the years. Ajanta’s team members are driven to fulfill its mission; a commitment to ‘Serving Global Healthcare needs with Empathy, Innovation & Technology’.
blank

03

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

About the Company : Calidrux Lifesciences LLP, established in 2023 in Gujarat, is a leading wholesaler of Active Pharmaceutical Ingredients (APIs), acid dyes, and more. Committed to quality and reliab...

Calidrux Lifesciences LLP, established in 2023 in Gujarat, is a leading wholesaler of Active Pharmaceutical Ingredients (APIs), acid dyes, and more. Committed to quality and reliability, we provide high-grade products to meet the diverse needs of the pharmaceutical and chemical industries. With a focus on excellence and customer satisfaction, we strive to deliver superior solutions that contribute to the growth and success of our clients, while ensuring compliance with industry standards.
blank

04

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

About the Company : Founded by chemists with years of working experiences in famous CRO companies in China, Excenen Pharmatech experienced in organic chemistry expecially in medicinal chemistry resear...

Founded by chemists with years of working experiences in famous CRO companies in China, Excenen Pharmatech experienced in organic chemistry expecially in medicinal chemistry research/discovery fields. Excenen PharmaTech is dedicated to serve the pharmaceutical, scientific research and development industries for 10 years. During the past 10 years we supplied building blocks, small molecules, inhitbitors to world's leading companies like Janssen (Johnson&Johnson), Gilead, Abbvie..., Universities like Duke University, University of Chicago, University of Barcelona, University of Pécs etc.
blank

05

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

About the Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated fo...

Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated formulation and development unit, and over 100 professionals, PRECISE has emerged as a one-stop solution for APIs, intermediates, and finished formulations. Leveraging our core strengths, we continue to strengthen our presence in the global market.
blank

06

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Polmacoxib

About the Company : Established in the year 2013 we help our clients to increase their R&D productivity in a cost-effective manner. We address a wide spectrum of client needs across the drug discovery...

Established in the year 2013 we help our clients to increase their R&D productivity in a cost-effective manner. We address a wide spectrum of client needs across the drug discovery and development value chain, which include: Medicinal Chemistry, Custom Synthesis, and Process R&D, Toxicology, Clinical Research, and Analytical Testing. Quality has been the major factor behind Venkatasai life sciences success in the wide competitive arena. We also ensure that all the products conform to strict quality standards. Owing to this, we are counted as one of the first and foremost choice of our clients that are spread across the world.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 1427301-99-2 / Polmacoxib API manufacturers, exporters & distributors?

Polmacoxib manufacturers, exporters & distributors 1

24

PharmaCompass offers a list of Polmacoxib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Polmacoxib manufacturer or Polmacoxib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Polmacoxib manufacturer or Polmacoxib supplier.

PharmaCompass also assists you with knowing the Polmacoxib API Price utilized in the formulation of products. Polmacoxib API Price is not always fixed or binding as the Polmacoxib Price is obtained through a variety of data sources. The Polmacoxib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Polmacoxib

Synonyms

301692-76-2, Cg100649, 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide, Cg-100649, Ij34d6ypao, Cg 100649

Cas Number

1427301-99-2

Unique Ingredient Identifier (UNII)

IJ34D6YPAO

About Polmacoxib

Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Localized Primary Osteoarthritis of Hip, and Localized Primary Osteoarthritis of Knee.

Polmacoxib Manufacturers

A Polmacoxib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Polmacoxib, including repackagers and relabelers. The FDA regulates Polmacoxib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Polmacoxib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Polmacoxib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Polmacoxib Suppliers

A Polmacoxib supplier is an individual or a company that provides Polmacoxib active pharmaceutical ingredient (API) or Polmacoxib finished formulations upon request. The Polmacoxib suppliers may include Polmacoxib API manufacturers, exporters, distributors and traders.

click here to find a list of Polmacoxib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Polmacoxib KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Polmacoxib Drug Master File in Korea (Polmacoxib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Polmacoxib. The MFDS reviews the Polmacoxib KDMF as part of the drug registration process and uses the information provided in the Polmacoxib KDMF to evaluate the safety and efficacy of the drug.

After submitting a Polmacoxib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Polmacoxib API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Polmacoxib suppliers with KDMF on PharmaCompass.

Polmacoxib GMP

Polmacoxib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Polmacoxib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Polmacoxib GMP manufacturer or Polmacoxib GMP API supplier for your needs.

Polmacoxib CoA

A Polmacoxib CoA (Certificate of Analysis) is a formal document that attests to Polmacoxib's compliance with Polmacoxib specifications and serves as a tool for batch-level quality control.

Polmacoxib CoA mostly includes findings from lab analyses of a specific batch. For each Polmacoxib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Polmacoxib may be tested according to a variety of international standards, such as European Pharmacopoeia (Polmacoxib EP), Polmacoxib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Polmacoxib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty